Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
CONCLUSION: Prior malignancy does not adversely impact survival of stage IV esophageal cancer. These results should be taken into consideration when designing clinical trials.
PMID: 29316808 [PubMed - as supplied by publisher]
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Expert Rev Gastroenterol Hepatol Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Databases & Libraries | Epidemiology | Esophagus Cancer | Gastroenterology | Skin Cancer | Squamous Cell Carcinoma | Study